bluebird bio
BLUE
#9803
Rank
HK$0.37 B
Marketcap
HK$38.69
Share price
0.00%
Change (1 day)
-75.63%
Change (1 year)

Earnings for bluebird bio (BLUE)

Earnings in 2025 (TTM): -HK$1.56 Billion

According to bluebird bio 's latest financial reports the company's current earnings are HK$0.10 Billion. In 2024 the company made an earning of -HK$1.88 Billion a decrease over its 2023 earnings that were of -HK$1.72 Billion. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for bluebird bio from 2012 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -HK$1.56 Billion-16.94%
2024 -HK$1.88 Billion9.52%
2023 -HK$1.72 Billion-17.54%
2022 -HK$2.08 Billion-18.85%
2021 -HK$2.56 Billion-46.87%
2020 -HK$4.82 Billion-21.79%
2019 -HK$6.16 Billion42.26%
2018 -HK$4.33 Billion65.59%
2017 -HK$2.62 Billion27%
2016 -HK$2.06 Billion58.42%
2015 -HK$1.3 Billion175.54%
2014 -HK$0.48 Billion138.96%
2013 -HK$0.2 Billion6.98%
2012 -HK$0.19 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
BioMarin Pharmaceutical
BMRN
HK$5.28 B-439.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Acceleron Pharma
XLRN
-HK$1.99 Billion 27.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
HK$70.84 B-4,654.41%๐Ÿ‡ซ๐Ÿ‡ท France
Sangamo Therapeutics
SGMO
-HK$0.85 Billion-45.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
HK$179.74 B-11,655.86%๐Ÿ‡บ๐Ÿ‡ธ USA
GlycoMimetics
GLYC
-HK$0.23 Billion-85.24%๐Ÿ‡บ๐Ÿ‡ธ USA